Form 4: Director Sells $30M LifeStance Health Shares

LifeStance Health Group Director Darren M. Black reported the sale of over 4.3 million shares of common stock for $7.01 per share, totaling approximately $30.25 million.

Summary

• Darren M. Black, a Director of LifeStance Health Group, Inc. (LFST), reported a sale of common stock.
• The transaction involved the disposition of 4,314,939 shares.
• The shares were sold at a price of $7.01 per share.
• The total value of the shares sold is approximately $30,247,742.39.
• Following this transaction, 29,209,776 shares are beneficially owned indirectly through various Summit Partners entities.
• The sale was executed on March 2, 2026.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a moderately negative signal due to the significant volume of shares sold by a director, which can raise questions about insider confidence, despite the potential for it to be a pre-arranged diversification.

Negatives

• A significant insider sale by a director, even if indirect, could be interpreted by the market as a lack of confidence or a move to diversify holdings.
• The sale of 4,314,939 shares at $7.01 per share represents a substantial divestment.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider sales, especially by directors, are closely watched by the market as they can signal management's perception of future company performance or simply be part of a pre-planned diversification strategy. This specific sale by a director associated with a major investment firm like Summit Partners could be part of a broader portfolio rebalancing.

Related Party Transactions

• Darren M. Black is a Managing Director and Member of Summit Master Company, LLC, which is affiliated with the entities that sold the shares.
• The shares were sold by Summit Partners Growth Equity Fund IX-A, L.P., Summit Partners Growth Equity Fund IX-B, L.P., Summit Investors GE IX/VC IV, LLC, Summit Partners Entrepreneur Advisors Fund II, L.P., and Summit Investors GE IX/VC IV (UK), L.P., all of which are related to Summit Master Company, LLC.

Stakeholder Impact

• Shareholders: May interpret the sale as a negative signal, potentially leading to downward pressure on the stock price.
• Investors: Will note the significant insider divestment as part of their due diligence.

Key Dates

Recommendation

The significant insider sale by a director, even if indirect through affiliated funds, introduces a negative sentiment. However, without additional information on the company's operational performance or the specific motivations behind the sale (which could include portfolio rebalancing or liquidity needs unrelated to company fundamentals), a 'hold' recommendation is prudent. Investors should monitor future filings and company performance for further clarity.

Keywords

LifeStance Health Group, LFST, Insider Trading, Form 4, Stock Sale, Director, Summit Partners, Equity Transaction